These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17087244)

  • 21. The use of an automated analyzer in the evaluation of antithrombin III and heparin.
    Scully MF
    Semin Thromb Hemost; 1983 Oct; 9(4):309-20. PubMed ID: 6658462
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
    Sakata T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the values of antithrombin III and other blood coagulation indices in liver cirrhosis without ascites and in the ascitic stage].
    Doncheva N
    Vutr Boles; 1989; 28(4):96-9. PubMed ID: 2596116
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of methods of freezing and thawing of blood plasma on the activity of procoagulants and antithrombin-III].
    Baryshev BA; Selivanov EA; Kobilianskaia VI; Andozhskaia IV; Kurenkova VV; Papaian LP
    Vestn Khir Im I I Grek; 2000; 159(6):55-6. PubMed ID: 11209233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An international collaborative study establishing a reference preparation for Antithrombin III.
    Kirkwood TB; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1980 Feb; 43(1):10-5. PubMed ID: 7404474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombin neutralization by antithrombin III depending upon the intensity of thrombin-formation in experimental and clinical surgical interventions].
    Pastorova VE; Tabakina TE; Ivanov AIu
    Vopr Med Khim; 1986; 32(5):28-32. PubMed ID: 3776113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of antithrombin III laboratory tests.
    King PG; Huang AH; Palkuti HA; Farris VL
    Am J Clin Pathol; 1980 Apr; 73(4):537-40. PubMed ID: 7369177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
    Kussmann J; Hirche H; Sengupta R
    Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.
    Bounameaux H; Marbet GA; Lämmle B; Eichlisberger R; Duckert F
    Am J Clin Pathol; 1980 Jul; 74(1):68-73. PubMed ID: 7395817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. False assignment of familial antithrombin III deficiency with the von Kaulla assay.
    Cosgriff TM; Hershgold EJ; Martin BA; Carlson KS
    Am J Clin Pathol; 1983 Nov; 80(5):697-9. PubMed ID: 6416053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency.
    Winter JH; Fenech A; Bennett B; Douglas AS
    Br J Haematol; 1984 Jul; 57(3):527-37. PubMed ID: 6743570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?
    Ungerstedt JS; Schulman S; Egberg N; Antovic J; Blombäck N
    Blood; 2002 Mar; 99(6):2271-2. PubMed ID: 11902137
    [No Abstract]   [Full Text] [Related]  

  • 34. Clotting factor concentrates in clinical practice. Standardization and assay.
    Barrowcliffe TW
    Semin Thromb Hemost; 1993; 19(1):73-9. PubMed ID: 8456326
    [No Abstract]   [Full Text] [Related]  

  • 35. [Surveillance of women taking oral contraceptives by determination of antithrombin III].
    Benoit MO; Raichvarg D; Caillens H; Neau C
    Nouv Presse Med; 1979 Feb; 8(7):528-9. PubMed ID: 461171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.
    Kovács B; Bereczky Z; Selmeczi A; Gindele R; Oláh Z; Kerényi A; Boda Z; Muszbek L
    Clin Chem Lab Med; 2014 Dec; 52(12):1797-806. PubMed ID: 24968404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis.
    Vaziri ND; Shah GM; Winer RL; Gonzales E; Patel B; Alikhani S; Nguyen QX; Yamamoto J
    Thromb Res; 1989 Jan; 53(2):173-80. PubMed ID: 2522249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of thrombin-antithrombin complexes in hypercoagulability conditions. Analysis of 182 cases].
    Zuazu-Jausoro I; Borrell M; Urrutia T; Oliver A; Montserrat I; Mateo J; Ribera L; Fontcuberta J
    Sangre (Barc); 1990 Oct; 35(5):375-9. PubMed ID: 2291147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
    Dorn-Beineke A; Dempfle CE; Bertsch T; Wisser H
    Thromb Res; 2005; 116(2):171-9. PubMed ID: 15907533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.